Cargando…
Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
The study of cytokine storm in COVID-19 has been having different edges in accordance with the knowledge of the disease. Various cytokines have been the focus, especially to define specific treatments; however, there are no conclusive results that fully support any of the options proposed for emerge...
Autores principales: | Palacios, Yadira, Chavez-Galan, Leslie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147078/ https://www.ncbi.nlm.nih.gov/pubmed/35631442 http://dx.doi.org/10.3390/ph15050616 |
Ejemplares similares
-
Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections
por: Ruiz, Andy, et al.
Publicado: (2021) -
TNF/IFN-GAMMA AXIS FAVORS SENESCENCE AND SEVERE INFLAMMATION ASSOCIATED WITH CELL DEATH IN PATIENTS WITH COVID-19
por: PALACIOS, Y., et al.
Publicado: (2022) -
Virulence Factors of Mycobacterium tuberculosis as Modulators of Cell Death Mechanisms
por: Ramon-Luing, Lucero A., et al.
Publicado: (2023) -
New Immunosuppressive Therapies in Uveitis Treatment
por: Mérida, Salvador, et al.
Publicado: (2015) -
Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)